Novellia Announces Formation of Advisory Board to Drive Strategic Growth

Novellia Announces Formation of Advisory Board to Drive Strategic Growth

NEW YORK, NY, May 1, 2023 - Novellia, Inc., an AI-enabled health data company harnessing the power of personal healthcare to drive precision medicine forward, is proud to announce its founding advisory board of industry veterans. With an initial focus on developing custom digital registry solutions for life sciences companies and specialized hospital networks, this esteemed group of industry leaders will provide strategic guidance and expertise as Novellia advances its mission to create one of the most comprehensive patient health record data networks in the industry to accelerate and advance scientific research and innovation.

The Advisory Board members include:

●  Steve Olsen, MD, PhD - A medical oncologist for over 20 years and veteran biopharmaceutical industry executive with extensive experience leading drug and diagnostics development through medical affairs with some of the world's most transformative biopharma companies.

●  Marc Watrous, PhD - A healthcare and biotech executive with over 30 years of experience, recognized for launching more than 30 new medicines in hundreds of new indications across multiple therapeutic areas. Known for transformational leadership, operational excellence, and a deep understanding of the U.S. healthcare system and market access. 

●  Jitin Asnaani - A leading expert on health data interoperability, he developed the nation’s health data frameworks under the Obama Administration and has played key roles in some of the most iconic health data companies.

●  Nirav S. Kapadia, MD, MS - A radiation oncologist at the Dartmouth Cancer Center, who oversees quality, patient safety, and experience while holding academic roles. 

"This extraordinary team brings together pioneers in drug development, health data infrastructure and clinical practice to help us lay the foundation for a future where fragmented health data no longer limits therapeutic innovation or patient care," said Shashi Shankar, CEO of Novellia. "Their guidance will be instrumental as we work to transform how the healthcare ecosystem leverages longitudinal health data, starting with our custom digital registry solution that can provide impactful insights that can reshape how diseases are understood, treatments are developed, and care is delivered."

This milestone represents a pivotal step forward for Novellia, reinforcing its position as an innovator in healthcare technology and its commitment to driving meaningful change in patient care.

For more information about Novellia, please visit our website

Read more